Samarth Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 06-07-2024
- Paid Up Capital ₹ 0.85 M
as on 06-07-2024
- Company Age 22 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -97.29%
(FY 2022)
- Profit -132.95%
(FY 2022)
- Ebitda -93.24%
(FY 2022)
- Net Worth -41.59%
(FY 2022)
- Total Assets -87.64%
(FY 2022)
About Samarth Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.85 M, as per Ministry of Corporate Affairs (MCA) records.
Ravindra Satalkar, Popat Kardile, Anil Athare, and Two other members serve as directors at the Company.
- CIN/LLPIN
U85110PN2002PTC016925
- Company No.
016925
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Ahmed Nagar, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samarth Diagnostics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravindra Satalkar  | Director | 16-Apr-2002 | Current |
| Popat Kardile | Director | 16-Apr-2002 | Current |
| Anil Athare | Director | 16-Apr-2002 | Current |
| Ashok Kale | Director | 16-Apr-2002 | Current |
| Vijay Patil | Director | 16-Apr-2002 | Current |
Financial Performance of Samarth Diagnostics.
Samarth Diagnostics Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 97.29% decrease. The company also saw a substantial fall in profitability, with a 132.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 41.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samarth Diagnostics?
In 2019, Samarth Diagnostics had a promoter holding of 99.86% and a public holding of 0.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Yashada Multitrade Private LimitedActive 18 years 9 months
Popat Kardile and Ashok Kale are mutual person
- Athare Patil Memoriaathare Patil Memorial Hosptandresearch Centre PvtltdActive 33 years 7 months
Anil Athare is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Samarth Diagnostics?
Unlock and access historical data on people associated with Samarth Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samarth Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samarth Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
